![](https://endpts.com/wp-content/uploads/2023/05/Marino-Garcia-Dianthus-tile.jpg)
Marino Garcia, Dianthus Therapeutics CEO
Dianthus teases preclinical data for autoimmune drug as it starts clinical trials
Dianthus Therapeutics has unveiled in vitro results of its drug candidate in a pair of autoimmune disease models, supporting recent efforts to start mid-stage studies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.